Meridian Dental Partners
Operations
Finance
Growth
Clinical
Patients
Payroll
DENTOPS · CONFIDENTIAL · BOARD REVIEW

Where the money goes, who sees it, and what to do next.

A connected report across all three Meridian Dental Partners locations and every DentOps pillar — Operations, Finance, Growth, Clinical, RCM and Procurement. From the first inbound lead to the collected dollar. The story neither a PMS, a phone system, nor the accounting ledger can tell alone.

Reporting periodFeb 16 — May 16, 2026 (T90)
Trend backdropMay 2025 — May 2026
LocationsPlano · Frisco · Southlake
Practice profileMultispecialty DSO · US
Providers9 dentists · 12 RDH
Visits (T90)6,650
Revenue$13.4M
01 The Picture

Meridian is worth ~$28M today. $1.73M/yr is recoverable — and it takes the group to ~$37M.

A healthy group, not a turnaround — 26.2% EBITDA margin, revenue +12% YoY. The opportunity is execution. Across the pillars there's $1.23M/yr of revenue you're not capturing and $0.50M/yr of cost you're overspending; together they lift margin toward ~35% and add +$9M of enterprise value at the group's 8.1× multiple. Below: what's working, then the five things to act on — each with what it's worth and what to do.

$1.73M
RECOVERABLE PER YEAR $1.23M of revenue not captured (Operations + Growth + RCM, plus Clinical net-new) and $0.50M of cost overspent (payroll, lab, supply). No double-count — ranked, with the play, in the tabs that follow.

What's working — credit where it's due

The five things to act on — ranked · what it is · what it's worth · what to do

1
Case acceptance is the biggest single leak. The group converts 62.6% of presented treatment (Plano 71%, Southlake just 41%) — the CRM shows the leads, the PMS shows the diagnoses, but the conversion falls between them. Worth $420K/yr. Do: scripted day-7/14/30 follow-up + a same-day acceptance protocol, and re-book the $210K diagnosed-but-unscheduled backlog at near-zero acquisition cost. See Growth.
2
Southlake is sub-scale and losing margin per hour. Schedule utilization sits at 51% and Dr. Reyes runs −$28/chair-hour (loaded cost above revenue). Invisible on the P&L because group income covers it — it's a utilization problem, not a clinical one. Do: lift utilization toward 70%, right-size the rota to demand, rebalance the provider mix. See Three Locations + Provider Economics.
3
Front-of-house is leaking demand it already has. Walkout retention 41%, missed-call rate 18%, recall recovery 15%. The phone system shows the abandoned calls; the PMS shows the empty chairs. Worth $315K/yr. Do: book the next appointment before the patient leaves, answer & convert abandoned calls, and work the no-future-appointment list. See Operations.
4
Not every billable dollar reaches the bank. Denial rate 9% (target 4%), clean-claim 88%→96%, $96K of delivered procedures unbilled, and dollars aging past 90 days. Worth $315K/yr. Do: fix denials at the source (documentation), work the 90+ AR before timely-filing closes it, and bill the unbilled. See RCM.
5
$0.50M of cost is overspent vs benchmark. Payroll-to-production gap ($250K, Southlake-led), supply / GPO compliance ($150K), and lab ($100K). It's already EBITDA, so at the 8.1× multiple it's worth +$4M of enterprise value. Do: right-size payroll to production, consolidate vendors onto the ACE DSN contract, and hold a lab remake SLA. See Finance + Procurement.
Plain English

Why a "connected report" matters for a multispecialty group specifically.

A multispecialty DSO runs five businesses at once — front-of-house demand, chair supply, the treatment funnel, clinical diagnosis, and the revenue cycle — plus the cost base underneath (payroll, lab, supply). A patient touches the practice through the CRM (the inbound enquiry), the phone system (every callback and reschedule), the PMS (every exam, image, diagnosis and visit), the lab (crowns and prosthetics), the clearinghouse (every claim and denial), the accounting ledger (cost lines, payroll), and the recall book (lifetime value).

Any one system tells a partial truth. The PMS shows visits done; the phone system shows calls answered; the ledger shows cost. None of them can tell you whether the $420K of stalled case acceptance is stalled because the leads are weak, the front desk is overloaded, the provider's diary is full, or the financing keeps being declined. The connected report is the only place that question has an answer.

Think of it like an airline. The check-in counter, the gate, the bag belt and the cabin crew each have a screen with their slice. But it's only when you put them together that you discover the flight is leaving with 14 empty seats while 22 passengers were turned away at re-booking because nobody could see both screens at once. That's what this report does for Meridian.
02 Headline Numbers

The trailing-90-day picture across all six pillars.

Group-level metrics for Feb 16 – May 16, 2026. Each tile is colour-coded by which DentOps pillar owns the number. Site-level breakdown follows in Tab 04.

Finance
Production (T90)
$3.35M
+12.1% vs prior 90 days
Finance
EBITDA margin
26.2%
$3.5M on $13.4M annualised
Finance
Group valuation
~$28M
Path to ~$37M on recapture
Growth
New patients (T90)
612
Across 3 locations
Operations
Visits / procedures (T90)
6,650
9 dentists · 12 RDH
Clinical
Case acceptance
62.6%
Southlake 41% vs Plano 71%
Operations
Schedule utilization
75.4%
Range 51%–91% across sites
Operations
Walkout retention
41%
No next visit booked at checkout
Finance
Production / chair-hour
$487
Plano $610, Frisco $487, Southlake $284
RCM
Net collection rate
94%
9% first-pass denial rate
Patients
Recall compliance
71.2%
Southlake at 38% — clinical risk
Payroll
Payroll % of production
40.0%
$250K above benchmark
Payroll
Lab + materials % of production
12.0%
Frisco at 18% drags average
Growth
Unscheduled treatment
$210K
Diagnosed, not booked
RCM
Unbilled procedures
$96K
Completed, never claimed
All Pillars
Recoverable revenue (annual)
$1.73M
$1.23M revenue + $0.50M cost — Tab 09
Revenue trend — trailing 12 months
Monthly cash collected, group total
FINANCE
Production mix by service line (T90)
Share of $3.35M group production
CLINICAL
Lead source mix (T90)
Where the 1,847 inbound enquiries came from (→ 612 new patients)
GROWTH
Group P&L slice (T90)
Production · lab · provider payroll · staff + support · overhead · net
FINANCE + PAYROLL

Top-line vs gross margin · per service line · T90

The most important breakdown for a multispecialty group — which service lines actually generate the margin. Restorative + oral surgery = 30% of procedures but 49% of total gross margin. The CEO's question: is the mix shifting toward the high-margin specialties fast enough, and is hygiene feeding them?

Service line Procedures T90 Avg $ Top-line $ Gross margin $ Margin % % of total margin
Hygiene & perio 3,020 $155 $468K $318K 68% 17%
Restorative (fillings / crowns / bridges) 1,790 $535 $957K $517K 54% 27%
Endodontics 400 $1,180 $472K $274K 58% 14%
Oral surgery & implants 210 $3,450 $724K $398K 55% 21%
Cosmetic & ortho (veneers / clear aligners) 95 $4,950 $470K $282K ★ 60% 15%
Exams & diagnostics (new-patient exams / imaging) 1,135 $230 $260K $117K 45% 6%
Group total (6,650 procedures · T90 production) 6,650 $504 $3.35M $1.91M 56.9% 100%

Full deep-dive on the mix in Tab 13 · The Service-Mix Story →

03 What's Working

Eight things the group is doing right — credited to the people doing them.

Before we get to the leaks. The basics across the group are largely sound, which is why the recoverable revenue figures in Tab 09 are large rather than terrifying.

• WIN 01 · OPERATIONS · PLANO

Plano schedule utilization is best-in-class.

91%

Across Plano's operatories, 91% of available chair-minutes are booked and billed. Industry benchmark for a well-run multispecialty practice is 78–82%.

Credit goes to: Plano diary management & Dr. Whitfield's 6-week rolling planning rhythm.
• WIN 02 · CLINICAL

Group clinical complication rate is below benchmark.

0.9%

Across 6,650 procedures in the trailing 90 days, surgical and endodontic complications requiring intervention ran at 0.9%. Published benchmark for comparable case mix is 1.5–2.2%.

Credit goes to: clinical protocols enforced across all 3 sites, mandatory imaging before surgical cases, and standardised endo workflows.
• WIN 03 · GROWTH · PLANO

Plano's case acceptance rate is exceptional.

71%

71% of treatment plans presented at Plano convert to a scheduled, paid case. Frisco is at 56%, Southlake at 41%. Plano's "present-and-book" protocol works.

Credit goes to: Plano coordinator Sophie Bennett & the integrated finance options presented chairside.
• WIN 04 · PATIENTS · PLANO

Plano recall compliance is best-practice.

86%

86% of active patients at Plano attend their scheduled 6-month hygiene recall. At this compliance level the practice catches restorative needs early and protects lifetime value.

Credit goes to: hygienist Joanna Park's pre-book-at-checkout flow.
• WIN 05 · FINANCE

Treatment-plan close rate held at >90% across all three sites.

90.8%

426 accepted treatment plans in T90 converted to 387 started cases. Only 39 stalled between acceptance and start — well within best-practice tolerance.

Credit goes to: integrated finance providers offering 0% financing up to $12K; book-at-acceptance workflow.
• WIN 06 · CLINICAL · COSMETIC

Cosmetic & ortho is the group's highest-margin line.

60% margin

95 cosmetic and clear-aligner cases T90 generated $470K production at 60% gross margin after lab and chair time — the richest margin in the group, ahead of restorative at 54%.

Credit goes to: Dr. Reyes building the cosmetic referral pathway from hygiene; Frisco picking up the playbook.
• WIN 07 · OPERATIONS · PLANO

Same-day treatment booking at Plano is exceptional.

64%

64% of patients accepting a plan at Plano leave with the next treatment visit already on the schedule. This collapses the diagnosis-to-treatment cycle from 47 days (group avg) to 19 days at Plano.

Credit goes to: Plano's integrated chairside workflow (findings → imaging review → plan → finance → date) in one visit.
• WIN 08 · LEADERSHIP

Meridian invested in Southlake early — ahead of the numbers in this report.

2 yrs

Southlake opened May 2024. Leadership knew the ramp would be slow. The numbers below are not failure — they are diagnosis. The investment is recoverable on the 90-day plan in Tab 12.

Credit goes to: the call to open Southlake at all, in a fast-growing DFW submarket with no comparable multispecialty group within a 15-minute drive.
04 Three Sites

Three sites. Three completely different management conversations.

The group P&L hides three radically different operational stories. The same KPI set that looks healthy at group level reveals a flagship, a growth site fighting a coordinator bottleneck, and a site that needs urgent action this quarter.

• FLAGSHIP · HOLD

Meridian Plano

Plano TX · est. 2014 · 4 dentists · 6 chairs
88
Health score (out of 100)
Production T90$1.74M
Schedule utilization91%
Procedures T903,450
New patients T90300
Case acceptance71%
Production per chair-hr$610
Recall compliance86%
Recoverable revenue$186K
• GROWTH · UNBLOCK

Meridian Frisco

Frisco TX · est. 2020 · 3 dentists · 4 chairs
71
Health score (out of 100)
Production T90$1.12M (+28% YoY)
Schedule utilization78%
Procedures T902,210
New patients T90210
Case acceptance56%
Production per chair-hr$487
Recall compliance71%
Recoverable revenue$412K
• STRUGGLING · URGENT

Meridian Southlake

Southlake TX · est. 2024 · 2 dentists · 3 chairs
48
Health score (out of 100)
Production T90$0.49M
Schedule utilization51%
Procedures T90990
New patients T90102
Case acceptance41%
Production per chair-hr$284
Recall compliance38%
Recoverable revenue$452K
Reading the three sites together

The same KPI set tells three different stories.

Plano is operating near the ceiling of what a 6-chair multispecialty practice can do. The 90-day move at Plano is not to push utilization higher (it's already 91%) but to capture more value per chair-hour by shifting mix toward the high-margin specialty and cosmetic lines.

Frisco has the demand (the biggest new-patient inflow in the group) but is choking on the operational capacity to convert it. The diagnosis is concrete: a single overloaded treatment coordinator, a lab supplier with an above-average remake rate, and complex cases taking longer to turn around than at Plano. All three are fixable. See Tabs 06, 08.

Southlake needs urgent intervention. The site is two years old, the clinicians are good, but every single connected KPI is below target — call answer, case acceptance, schedule utilization, recall compliance, production per hour. The good news: each one has a defined 30/60/90-day action with a known revenue uplift. See Tab 12, P1 column.

Think of the three sites as a 50-meter swimming pool, a leaky garden hose, and a closed tap. Plano is the pool — full, working hard, but bounded by physical size. Frisco is the hose — plenty of water pressure (leads) but losing flow through a dozen small holes. Southlake is the tap — the water is sitting on the supply side, but very little is making it through to the bucket. Each needs a completely different fix.
05 Enquiry → Treatment

One patient. Ten steps. Six systems underneath.

Every patient walks this same journey from inbound enquiry to completed treatment and recall. At each step, a different DentOps pillar owns the data. The drop-off at each step is shown below — because if you don't see the drop-off, you can't fix the leak.

Patient journey funnel
Group total · trailing 90 days · Feb 16 — May 16, 2026
ALL PILLARS
Inbound enquiries Growth Web form · phone · referral · walk-in
1,847100%
Call answered / form actioned Operations Coordinator picks up or follows up within SLA
1,46379.2%−384
New-patient appointment booked Growth First visit in the schedule, with a date
1,08258.6%−381
New-patient exam attended Clinical Patient showed up, clinical assessment completed
99453.8%−88 FTA
Diagnostics & imaging complete Clinical X-rays, charting and findings recorded
80643.6%−188
Treatment plan presented Growth Plan with options + price + finance
68136.9%−125
Treatment plan accepted Growth Patient said yes — either in person or by callback
42623.1%−255
Deposit / financing secured Finance Cash, card or finance package executed
38721.0%−39
Treatment started Clinical First treatment visit completed
35819.4%−29 deferred
Treatment plan completed Clinical All planned phases delivered
31216.9%−46 in progress
Booked into recall Patients Next hygiene recall scheduled at checkout
22712.3%−85 not booked
!

THE BIGGEST SINGLE LEAK

From 681 plans presented to 426 accepted — group case acceptance is 62.6%, losing 255 plans at this single step. Plano converts 71%; Frisco 56%; Southlake 41%. Closing the gap to Plano's rate across Frisco and Southlake recaptures ~$420K/yr of diagnosed treatment that is currently presented and walks away. A further $210K sits in treatment that was accepted but never scheduled. See Tab 06 for the coordinator-bottleneck diagnosis.

Where the systems hand off

Six pillars, ten steps, one patient.

The journey above is colour-coded by which pillar owns each step. The handoffs are where things go wrong:

Step 2 → 3 (Ops → Growth): a call gets answered but the coordinator doesn't book a first visit. 384 enquiries vanish here.
Step 5 → 6 (Clinical → Growth): findings are recorded but a treatment plan never goes back to the patient. 125 vanish here.
Step 7 → 8 (Growth → Finance): patient says yes but the deposit or financing doesn't land. 39 vanish here.
Step 10 → 11 (Clinical → Patients): treatment completed but no recall booked. 85 patients exit unprotected.

Each of these handoffs is between two pillars. Each one is invisible if you only look at one pillar's dashboard. This is the case for DentOps.

06 Coordinator Bottleneck

The Frisco story: when you have more demand than capacity to convert it.

Meridian Frisco brought in 386 inbound enquiries this quarter — the most of any site in the group. It converted only 56%. Three pillars together explain why, and one hire fixes it.

GROWTH · CRM

Frisco has the largest lead pipeline in the group.

Inbound leads (T90)386
% from paid (Meta + Google)64%
Marketing spend (T90)$38,420
Cost per lead$99.50
Consults booked from leads216
Lead → consult conversion56%
Stalled leads >14 days no contact170

OPERATIONS · TELEPHONY

The phone system shows when the leads bleed out.

Inbound patient calls (T90)681
Call answer rate81%
Missed calls (T90)130
Missed call hours, weekly avg8.4 hrs
Worst hour: Tue 2–4pm42% answer
Worst hour: Thu 11–1pm51% answer
Median callback time18.5 hrs

PAYROLL · STAFFING

The payroll record explains both numbers.

Coordinator FTE at Frisco1.0
Coordinators at Plano (smaller pipeline)2.0
Coordinator cost (Frisco, T90)$10,500
Coordinator workload — consults216 consults
Coordinator workload — plan follow-ups204 open plans
Coordinator workload — deposit chasing62 stages
Total open work-items per coord482

CLINICAL · THE COST OF NOT FIXING

Frisco's chairs are sitting idle while leads stall.

Schedule utilization78%
Idle chair-hours per week (group avg)28 hrs
Frisco idle chair-hours per week21 hrs
Stalled treatment plan value >30d$186,400
Lapsed lead value (no-contact >14d)$144,800
Marketing $ per converted patient$178
Marketing $ per captured case$317
Σ

THE CONNECTED DIAGNOSIS

Frisco is paying $38K/quarter for paid leads, generating 681 inbound calls, missing 130 of them (mostly Tue and Thu afternoons), letting 170 leads go cold and 204 treatment plans stall >30 days, all because one coordinator is doing the work of two. The chairs are sitting idle 21 hours a week waiting for the schedule to fill. The fix is $42K/yr fully loaded for a second coordinator. The recovered revenue at 50% conversion of the stalled pipeline is $186K in the first 90 days alone.

Frisco — call answer rate heatmap by hour and day
Last 90 days · darker = lower answer rate
OPERATIONS
Mon
Tue
Wed
Thu
Fri
9–11am
88%
85%
86%
78%
81%
11am–1pm
79%
68%
76%
51%
72%
1–2pm
61%
54%
63%
58%
66%
2–4pm
76%
42%
71%
58%
64%
4–6pm
82%
74%
84%
73%
85%

The two worst cells (Tue 2–4pm at 42%, Thu 11–1pm at 51%) are when the single coordinator is in back-to-back consults. These two slots alone account for 68 of the 130 missed calls T90. A second coordinator covers exactly these gaps.

07 Provider Economics

Production per chair-hour − fully-loaded cost per chair-hour = margin per provider per site.

One of the most important numbers in a multispecialty group: what is each provider's chair-hour actually worth? Three pillars (Ops, Finance, Payroll) must join cleanly to compute it. Meridian Southlake is currently negative.

Provider · Site Role Chair hrs T90 OPS Util % Production FIN Prod / chair hr Fully-loaded cost / hr PAY Margin / hr
Dr. James Whitfield
Plano · Principal · Oral surgery / implants
Principal 1,124 93% $0.94M $836 $298 +$538
Dr. Priya Mehta
Plano · General + restorative
Associate 1,058 88% $0.80M $756 $262 +$494
Dr. Marcus Chen
Frisco · Principal · Endodontics
Principal 1,012 82% $0.61M $603 $285 +$318
Dr. Sarah Okafor
Frisco · General + restorative
Associate 894 74% $0.51M $570 $241 +$329
Dr. Elena Reyes
Southlake · Principal · General + cosmetic
Principal 832 53% $0.28M $337 $365 −$28
Locum (Southlake rota)
Southlake · 0.5 FTE
Locum 386 48% $0.21M $544 $420 +$124
Production providers 5.5 FTE 5,306 75% $3.35M $631 $302 +$329

Restorative/specialty production providers shown above (5.5 FTE). The group's 9 dentists also include part-time general associates and hygiene-led providers whose chair-hours sit outside this margin-per-hour view.

$28/hr
DR. REYES AT SOUTHLAKE · MARGIN PER CHAIR HOUR Every chair hour at Meridian Southlake with the principal currently destroys $28 of margin. Across 832 hours T90 that is $23,300 of operational loss, masked at group level by Plano's profitability. The lever is not the clinician's skill (it's fine) — the lever is utilization. Pushing Southlake from 53% to 70% util alone moves margin per hour from −$28 to +$138.
What "fully-loaded cost per hour" means

The cost number that nobody computes — until it's too late.

Fully-loaded cost per chair hour = base salary or day rate + payroll taxes + benefits + allocated overhead (assistant cost, room cost, sterilization, supplies, software) + employer's portion of insurance · divided by actually-billed chair hours.

This is the true denominator for provider profitability. A provider on a $250K package, with full overhead allocation of $180K (typical for a multispecialty group), needs to deliver $430K of production just to break even. At 1,500 billed chair hours/yr that is $287/hr break-even. At 900 hours (53% util), break-even jumps to $478/hr.

It's the airline empty-seat problem. The plane's flying anyway. The crew, the fuel, the gate fees — all sunk. Every unsold seat is pure margin loss. A dental chair is the same. The cost is paid whether the chair is occupied or not. Meridian Southlake is currently flying with half-empty seats.
08 Case-Mix Economics

The implant-and-crown case — what it really costs, what it really earns, and why Frisco is leaking margin.

Five pillars must join cleanly to give you the answer: Clinical (case complexity), Finance (revenue and material cost), Payroll (provider and assistant time), Operations (chair time), Patients (lifetime value from ongoing recall). Below: the group's highest-value multispecialty case — a single implant with custom abutment and crown — modelled at all three sites.

Model case: single implant — surgical placement, custom abutment, definitive crown, conventional financing
Avg case value at Meridian · T90 actual deliveries · numbers below are the group average; site-specific variances follow
Revenue components
Consultation + imaging fee$250
Implant surgical placement$2,400
Custom abutment$650
Definitive crown$1,650
Healing & review visits$250
Total case revenue$5,200
Direct costs CLI PAY
Implant fixture$420
Abutment & components$180
Crown lab fee$420
Provider time (3.0 hrs × loaded rate)$750
Assistant time$130
Total direct cost$1,900
Indirect & opportunity
Allocated overhead (room, sterilization)$360
Coordinator + admin time$110
Card / finance fee (2.4%)$125
Marketing attributable cost$120
Allowance for lab remake (2.3% group)$45
Total indirect$760
Case revenue
$5,200
Total cost
$2,660
Net margin / case
$2,540
Margin %
48.8%

Same case, three sites.

Component Plano Frisco Southlake Group avg
Case revenue (avg actual) $5,350 $5,150 $4,950 $5,200
Provider time · hours per case 2.8 3.4 3.6 3.0
Provider cost per case $700 $850 $900 $750
Lab cost per case $390 $520 $440 $420
Lab remake rate 1.2% 4.2% 2.4% 2.3%
Total cost per case $2,420 $2,920 $2,980 $2,660
Net margin per case $2,930 $2,230 $1,970 $2,540
Margin % 54.8% 43.3% 39.8% 48.8%
Implant cases T90 110 70 30 210
Implant-case margin T90 $322,300 $156,100 $59,100 $537,500
Δ

FRISCO IS LEAKING $700 OF MARGIN PER IMPLANT CASE

Frisco runs 36 minutes longer per case (provider time leakage), spends $130 more on lab (different supplier), and remakes 4.2% of crowns vs. Plano's 1.2%. At Frisco's current run rate of ~280 implant cases/yr, bringing those three lines in line with Plano recovers $135K of annual margin. Lab supplier review, clinical protocol benchmarking against Whitfield's technique, and a 6-week mentoring pair-up are the three plays in the 90-day plan.

09 Recoverable Revenue

$1.73M sitting in the gaps between systems — $1.23M of revenue to capture, $0.50M of cost to recover.

Every recoverable line below comes from a cross-pillar query. None of them are visible from a single system's dashboard. The revenue lines each have a named patient list behind the number; the cost lines trace to the ledger and the supply contracts. Ordered by size · the 90-day plan in Tab 12 sequences them.

Recoverable stack · annualised · $1.23M revenue + $0.50M cost

$1,730,000
Stalled & unscheduled treatment GRO 255 plans presented not closed (62.6% acceptance) + $210K diagnosed, never scheduled
$420,00024.3% · revenue
Front-of-house & scheduling gaps OPSGRO Missed callbacks (63% at Southlake) + 41% walkout retention; book-at-checkout protocol
$315,00018.2% · revenue
Unbilled procedures, denials & underpayments RCM $96K completed-never-claimed + 9% first-pass denial rate + payer underpayments
$315,00018.2% · revenue
Payroll above benchmark PAY Payroll 40% of production vs benchmark; rota design + associate-mix rebalancing
$250,00014.5% · cost
Lapsed recall reactivation PATCLI 532 patients overdue 9–18 months (Southlake recall 38%); reactivation campaign
$180,00010.4% · revenue
Supply spend & GPO compliance FIN Off-contract spend + ACE DSN GPO tier compliance; standardise ordering across 3 sites
$150,0008.7% · cost
Lab spend & remake rate FINCLI Frisco remake rate 4.2% vs Plano 1.2% + lab supplier consolidation
$100,0005.8% · cost
How to read the stack

Every line traces to a named patient list. Nothing is theoretical.

The $96K of unbilled procedures is a specific list of completed treatments — clinical notes show the procedure done; the clearinghouse has no matching claim. The billing team at all three sites can be handed that list tomorrow morning and run it through the claim flow. Roughly one week of work for cash already earned.

The $420K of stalled and unscheduled treatment is specific patients who sat in front of a provider, said they were interested, and went home to think about it — or accepted but never got booked. Each comes with the case value, the days since plan presentation, and the reason they hesitated (where captured). Call list ready to print.

This is not a "future opportunity". This is money the practice has already earned — in clinical labour, in marketing spend, in chair time, in patient trust — or already overspent, that simply isn't captured because somebody's system doesn't talk to somebody else's system. The connected report makes the conversation possible.
10 Recall: The Moat

The recall book is the practice's recurring-revenue moat.

A patient who attends their 6-month hygiene recall for 5 years generates an average of $1,200 of additional high-margin hygiene + restorative revenue — and surfaces decay and perio early, when it is cheap to treat. The book is a financial asset and a clinical risk-mitigation asset at the same time. It is currently leaking at two of three sites.

PATIENTS · PLANO

The benchmark.

Active recall patients2,480
Compliance — 6mo recall attended86%
Compliance — 12mo recall attended81%
Avg hygiene fee / visit$148
Annual recurring rev per active patient$256
Total annual recurring rev (Plano)$635K
Decay/perio progression T12mo0.4%

PATIENTS · FRISCO

Drifting.

Active recall patients1,760
Compliance — 6mo recall attended71%
Compliance — 12mo recall attended62%
Avg hygiene fee / visit$140
Annual recurring rev per active patient$198
Total annual recurring rev (Frisco)$348K
Decay/perio progression T12mo1.1%

PATIENTS · SOUTHLAKE

The moat is open.

Active recall patients1,060
Compliance — 6mo recall attended38%
Compliance — 12mo recall attended29%
Avg hygiene fee / visit$128
Annual recurring rev per active patient$94
Total annual recurring rev (Southlake)$100K
Decay/perio progression T12mo2.4%
$73K/yr
SOUTHLAKE · RECALL REACTIVATION OPPORTUNITY Reactivating Southlake's 304 lapsed recall patients toward Plano's 86% compliance level is worth $73K/year of recurring revenue — and reduces the decay/perio progression rate from 2.4% to under 0.6%, catching restorative needs early instead of as emergencies (a further cost-avoidance of roughly $16,500/year in unplanned chair time).
Why this is the moat

Multispecialty practices live or die on the recall book.

The patient who attends their 6-month hygiene recall is the closest thing a dental practice has to a subscription business. The patient is high-trust, high-engagement, very unlikely to switch providers, and refers an average of 1.4 new patients over their next five years. They also represent the practice's clinical liability tail: a patient not under recall is a patient whose decay and perio surface as emergencies — often in someone else's clinic.

Plano's 86% compliance is the result of one specific workflow: the next recall appointment is booked at the same checkout where today's visit ends. The patient does not leave the building without the next appointment in the schedule. Frisco has the workflow on paper but enforcement is patchy. Southlake doesn't have the workflow at all.

This is a free 90-day fix. No new staff. No new system. Just a workflow rollout.

Lapsed recall cohort — sample callback list (top 8 by recoverable LTV)
Generated from cross-query: dim_patients.last_visit_date + fact_appointments.last_attended + fact_treatment_codes.recall_due
PATIENTS · SOUTHLAKE
Patient-3284Crown + perio maintenance · last attended Dec 2024$3,800 LTV17mo lapsed
Patient-2917Implant + 2 restorations · last attended Mar 2025$2,400 LTV14mo lapsed
Patient-4101Anterior crown + hygiene · never returned$1,800 LTV18mo lapsed
Patient-35522 fillings + recall · cancelled 1 recall$2,200 LTV9mo lapsed
Patient-4288Root canal + crown · last attended Feb 2025$3,600 LTV15mo lapsed
Patient-37442 premolar fillings · never returned$2,000 LTV18mo lapsed
Patient-4012Single molar crown · cancelled 6mo recall$1,600 LTV10mo lapsed
Patient-3198Bridge + perio maintenance · last attended Nov 2024$2,900 LTV17mo lapsed

Full list of 304 patients exportable to CSV for outbound campaign. PII masked here per DentOps security policy.

11 Site Deep Dive

All three sites, side by side, on every KPI that matters for a multispecialty group.

One page. 36 KPIs × 3 sites. Where each pillar owns each row. Outlier cells flagged. Use this as the management agenda — one line item per row.

KPI Pillar Plano Frisco Southlake Group / Target
Growth · lead pipeline
Inbound enquiries T90GRO4123862481,046 / target 1,200
Lead source: paid digital %GRO42%64%71%55% group
Lead source: referral %GRO38%22%14%26% group
Cost per leadGRO$68$99.50$118$89 group
Lead → consult conversionGRO74%56%41%59% group / 70% target
Stalled leads >14 days no contactGRO2817098296
Operations · telephony & diary
Inbound call volume T90OPS1,1846815122,377
Call answer rateOPS92%81%51%79% group
Missed callbacks T90OPS95130271496 (out: 68 recovered)
Schedule utilizationOPS91%78%51%75% / 78% target
White space hrs/weekOPS9.421.038.422.9 group
FTA rateOPS4.8%8.6%12.4%8.1% group
Same-day-conversion at consultOPS64%48%28%49% group
Clinical · procedures & outcomes
New-patient examsCLI412386196994
Diagnostic imaging studiesCLI348312146806
Implant casesCLI1107030210
Crown & bridge unitsCLI5204101801,110
Endo casesCLI168132110410
Complication rateCLI0.7%0.8%1.9%0.9% group
Treatment completion rateCLI99.2%98.6%97.1%98.8% group
Lab remake rateCLI1.2%4.2%2.4%2.3% group
Crown delivery TAT (days)CLI12141814 group
Finance
Production T90FIN$1.74M$1.12M$0.49M$3.35M
Production per chair-hourFIN$610$487$284$487 / $450 target
Avg treatment-plan valueFIN$1,850$1,620$1,340$1,700 group
Case acceptance rateFIN71%56%41%62.6% group
Financing take-upFIN58%66%71%63% group
Net collection rateFIN96%94%90%94% group
Unbilled procedures >30dFIN8191138 / target < 5
Patients
Active recall patientsPAT2,4801,7601,0605,300
Recall compliancePAT86%71%38%71.2% group
Lapsed cohort >9moPAT62166304532 total
Recurring rev / active pt / yrPAT$256$198$94$204 group
Decay/perio progression T12moPAT0.4%1.1%2.4%1.1% group
Referral patients (T90)PAT1578635278
Payroll & cost
Dentist FTEPAY4.03.02.09.0
Coordinator FTEPAY2.01.00.53.5 / target 5.0
Provider payroll % of productionPAY22.4%26.1%31.8%25.3% group
Lab + materials % of productionPAY11.0%14.0%13.0%12.0% group
Margin per chair-hourPAY+$516+$323+$48+$329 group
12 The 90-Day Plan

Sequenced actions. Early wins fund the harder work.

Ten action cards across three 30-day phases. Each card names which pillars supply the data and which pillar owns the work. Recoverable value $1.73M across the full sequence; $414K is bankable inside the first 30 days.

PHASE 1
Days 1–30 · Stop the bleed
$414K bankable
  • Run the unbilled-procedure recovery campaign at all 3 sites. 38 claims, 7 days of billing-team work, $96K cash. CLI FIN
  • Print Southlake's 304-name lapsed-recall callback list. Hygienist + front desk work a list of 25 patients/day; reactivation conversion expected 30%. $73K/yr recurring + clinical risk reduction. PAT CLI
  • Hire 2nd coordinator at Frisco. Job posted day 1, hired by day 21. Cost $42K/yr loaded. PAY GRO
  • Implement the "next-recall-at-checkout" flow at Frisco + Southlake. Workflow rollout, training, daily compliance check by manager. $58K/yr recurring uplift in Y1. PAT OPS
  • Block Tue 2–4pm and Thu 11–1pm at Frisco as call-protected slots until 2nd coordinator starts. ~$28K recovered missed-call value in interim. OPS
PHASE 2
Days 31–60 · Capture momentum
$412K addressable
  • Run the 204-name stalled case-plan recovery at Frisco with the new 2nd coordinator. Scripted follow-up at days 7, 14, 30. Expected conversion 35% — $144K of stalled value recovered. GRO CLI
  • Review & switch Frisco's lab supplier. 4.2% remake rate is double group average; commercial review with current supplier + RFP to two alternates. $58K/yr direct cost saving. CLI FIN
  • Pair-up: Dr. Whitfield mentors Dr. Chen on complex-case efficiency for 6 weeks. Target: bring per-case chair time from 8.9 to 8.3 hours. $46K/yr margin uplift on Frisco specialty cases. CLI PAY
  • Activate the 428-name missed-callback campaign (Southlake-weighted) via outbound dialler. $186K recoverable lead value at 25% conversion. OPS GRO
PHASE 3
Days 61–90 · Build the system
Structural — lasting
  • Hire 0.5 FTE additional coordinator at Southlake (combined with marketing analyst role). Funds Phase 1 momentum. PAY GRO
  • Re-pitch Southlake's Google Ads + Meta campaigns with the new Phase 1 case studies and reduced cost-per-lead target (current $118, target $82). +72 leads/month at lower CAC. GRO
  • Roll out the Plano "same-day-conversion at consult" protocol to Frisco + Southlake. Training in week 9; first cohort runs week 10–12. Target: lift Frisco acceptance from 56% to 65%, Southlake from 41% to 55%. $220K annualised value. GRO OPS CLI
  • Build the integrated recall + clinical-risk-tracking workflow so Southlake's decay/perio progression is monitored monthly, not annually. CLI PAT
  • Re-baseline the report. By day 90, re-run this connected report and measure realised vs forecast on each line. Adjust the next quarter's plan accordingly. OPS FIN

Priority action cards — the four critical ones.

• DO FIRST · P1 · WEEK 1
Unbilled procedure recovery — group-wide
38 completed procedures have no claim submitted. Clinical notes show procedure complete; the clearinghouse has no matching claim raised. Per-site: Plano 8, Frisco 19, Southlake 11. Total recoverable: $96,000 cash, executable in 7 days.
WHAT TO ACTUALLY DO Print the claim list per site. The billing team runs the claim-submission flow Monday morning of week 1. Practice manager signs off by Friday. By end of week 2, cash should be 80% landed.
CLI · DATA FIN · ACTION OPS · WORKFLOW
• DO FIRST · P1 · WEEK 1
Frisco coordinator hire
One overloaded coordinator is the upstream cause of: 130 missed inbound calls, 170 cold leads, 204 stalled treatment plans, 21 idle chair-hours/week. Cost to fix: $42K/yr loaded. Time to fix: 21 days from job ad to start. Lookback ROI: 4.4× in the first 90 days.
WHAT TO ACTUALLY DO Frisco practice manager posts ad week 1. Interview pipeline w2–w3. Offer + start w4. 90-day check-in tied to Tab 06 metrics (call answer rate, stalled plan count).
PAY · HIRE OPS · CAPACITY GRO · OUTCOME
• DO SOON · P2 · WEEK 5
Frisco lab supplier review & switch
Frisco remake rate is 4.2% vs group average 2.3% and Plano 1.2%. Two suppliers have submitted comparison quotes that come in $130/case lower with published remake rate <2%. Switch is reversible. $58K/yr direct cost saving + reduced clinical re-work + faster crown TAT.
WHAT TO ACTUALLY DO Group clinical lead + Frisco principal run a 4-week trial with Supplier B on the next 8 crown & bridge cases. Compare remake, fit, aesthetic outcome, TAT. Decision gate at week 8.
CLI · PROTOCOL FIN · COST PAY · OUTCOME
• DO SOON · P2 · WEEK 4
Southlake recall reactivation
304 lapsed recall patients at Southlake. Clinical risk (decay/perio progression already 2.4% vs group 1.1%) + recurring revenue moat. Reactivation campaign: SMS + phone + targeted incentive (free first review). $73K/yr recurring + $16.5K/yr clinical cost avoidance.
WHAT TO ACTUALLY DO Southlake hygienist owns the list. 25 calls/day × 12 working days. SMS reminder + complimentary first review offer. Target reactivation: 30% (91 patients). Tracking weekly in the connected dashboard.
PAT · DATA CLI · OUTCOME FIN · VALUE
Σ

FORECAST AT END OF 90 DAYS

If Phase 1 and Phase 2 are executed in full: group quarterly production moves from $3.35M to $3.80M (+13.4%), group schedule utilization moves from 75% to 81%, Southlake margin per chair-hour moves from −$28 to +$138 (positive for the first time), and the recoverable stack rebuilds to a new baseline of $420K (reflecting steady-state operational leakage at the size we've grown into).

13 The Service-Mix Story

11% of procedures. 50% of margin. The service-mix question the practice should ask every quarter.

A multispecialty group's P&L is not built from "visits." It's built from six service lines, each with materially different revenue, cost, and margin profiles. The CEO's question — "what's top-line vs gross margin per service line?" — is the single most important strategic frame. This tab answers it.

$2,970 / case
★ HIGHEST-MARGIN LINE · COSMETIC & ORTHO 60% margin · $282K margin contribution from 95 cases T90. Cosmetic and clear-aligner cases earn the practice $680 / chair-hour — the richest line in the group — and feed the recall book and the referral engine on the way through.
1
The 80/20: the three specialty lines — endo, oral surgery & implants, cosmetic & ortho — are 11% of procedures but 50% of total gross margin. Restorative is the engine ($517K, 27% of margin); hygiene is the feeder. The growth lever is not "more visits" — it's more of the right work.
2
Cosmetic & ortho is the unlock. 60% margin (highest in the group), $2,970 contribution per case, and it feeds directly off the hygiene base — the patient is already in the chair. Plano runs 55 cases T90, Frisco 30, Southlake just 10. The capability and marketing build at Southlake is the lever.
3
Exams and hygiene look like low margin — but that's the wrong lens. Exams sit at 45% margin and hygiene at 68%, yet hygiene is the single most valuable line in the group because of what it feeds: every recall visit is a chance to diagnose restorative and specialty work. Protect hygiene capacity; it is the top of the funnel.
4
The mix-shift math: every 1% of production shifted from exams/hygiene-only toward restorative + specialty is worth ~$22K/qtr of incremental gross margin at the current run-rate. Lifting Southlake's specialty share toward Plano's alone unlocks $80K+/qtr without adding chairs, payroll or marketing spend.

The full service-line economics matrix

Six service lines · T90 actuals · procedures, top-line, direct cost, gross margin $, margin %, contribution %, and $ per chair-hour. Top-line sums to the $3.35M group production; gross margin sums to $1.91M (56.9%). This is the same mix shown on the Headline Numbers tab, broken out in full.

Service line Procedures T90 Avg $ Top-line $ Direct cost $ Gross margin $ Margin % % total margin $/chair hr
Hygiene & perio 3,020 $155 $468K $150K $318K 68% 17% $185
Restorative (fillings / crowns / bridges) 1,790 $535 $957K $440K $517K 54% 27% $560
Endodontics 400 $1,180 $472K $198K $274K 58% 14% $640
Oral surgery & implants 210 $3,450 $724K $326K $398K 55% 21% $590
Cosmetic & ortho (veneers / clear aligners) 95 $4,950 $470K $188K $282K ★ 60% 15% $680
Exams & diagnostics (new-patient exams / imaging) 1,135 $230 $260K $143K $117K 45% 6% $230
Group total 6,650 $504 $3.35M $1.45M $1.91M 56.9% 100% $487
Σ

THE CONCENTRATION INSIGHT

Endo + oral surgery & implants + cosmetic & ortho combined: 705 procedures (11% of volume) generating $954K of margin (50% of margin contribution). A 1-point shift of production into these lines is worth ~$22K/qtr. The practice already has the clinical capability and the lab relationships — the constraint is upstream demand generation (Growth pillar lead-source quality) and downstream capability build at Southlake.

Service mix × site — where each line actually happens

Each site indexes toward a different mix. Plano is the premium-mix site (heavy on specialty + cosmetic). Frisco is balanced. Southlake leans on hygiene, exams and basic restorative, with very little specialty or cosmetic — which structurally caps its production-per-chair-hour at $284 vs Plano's $610.

Service line Plano cases / margin Frisco cases / margin Southlake cases / margin Group margin
Hygiene & perio 1,180 · $140K 1,120 · $110K 720 · $68K $318K
Restorative 760 · $270K 660 · $175K 370 · $72K $517K
Endodontics 168 · $130K 132 · $95K 100 · $49K $274K
Oral surgery & implants 110 · $225K 70 · $128K 30 · $45K $398K
Cosmetic & ortho 55 · $180K 30 · $80K 10 · $22K $282K
Exams & diagnostics 480 · $55K 410 · $42K 245 · $20K $117K
Site margin total (% of group margin) 2,753 cases · $1.00M (52%) 2,422 cases · $630K (33%) 1,475 cases · $276K (15%) $1.91M
Why this matters for the next 90 days

The mix shift is the highest-leverage move in the practice.

Hiring a coordinator costs $42K/yr. Switching a lab supplier saves $58K/yr. Reactivating 304 lapsed patients earns $73K/yr recurring. These are good moves — but they are all operational levers.

Mix shift is a strategic lever, not an operational one. Lifting Southlake's specialty + cosmetic share toward Plano's delivers +$80K of incremental gross margin per quarter with no new payroll, no new chairs, no new marketing spend. Just better case selection by the treatment coordinators and case-acceptance training that surfaces the right treatment for each patient's clinical situation (and for the practice's economics).

Think of it like a wine list. Every restaurant sells house wine. The margin difference between selling 100 bottles of house wine and selling 80 house + 20 reserve list is what separates a fine-dining restaurant from a chain. Meridian's reserve list is the specialty & cosmetic book. Right now Plano runs it, Frisco dabbles, Southlake barely opens it. That's the strategic question for FY27.